cidrap.umn.edu
85%
681
Heads of COVID vaccine firms promise dose ramp-up
Today during a House Committee on Energy & Commerce hearing, chief executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novovax addressed US lawmakers for the first time since July 2020 on the production of vaccines and when Americans could expect more doses.